{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:30:25Z","timestamp":1784251825828,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11030-024-10958-x","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T08:02:22Z","timestamp":1723622542000},"page":"2049-2061","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Computational drug repositioning for IL6 triggered JAK3 in rheumatoid arthritis using FDA database"],"prefix":"10.1007","volume":"29","author":[{"given":"Kaushani","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bavya","family":"Chandrasekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthy","family":"Sathish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglae","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirumurthy","family":"Madhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"issue":"6","key":"10958_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"B Jacqueline","year":"2018","unstructured":"Jacqueline B, Syed AAR, Ayman MS, Sultan SA, Duc PD, Rais AA, Jasmin A (2018) Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract 27(6):501\u2013507. https:\/\/doi.org\/10.1159\/000493390","journal-title":"Med Princ Pract"},{"issue":"4","key":"10958_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.berh.2008.07.001","volume":"22","author":"C Arvind","year":"2008","unstructured":"Arvind C, Abdel-Nasser A (2008) Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol 22(4):583\u2013604. https:\/\/doi.org\/10.1016\/j.berh.2008.07.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10958_CR3","doi-asserted-by":"publisher","first-page":"13976","DOI":"10.1074\/jbc.271.24.13976","volume":"271","author":"W Verbsky","year":"1996","unstructured":"Verbsky W, Erika AB, Yi-Fu F, Liping Y, David AR, Fields LE (1996) Expression of janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J Biol Chem 271:13976\u201313980. https:\/\/doi.org\/10.1074\/jbc.271.24.13976","journal-title":"J Biol Chem"},{"issue":"1","key":"10958_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"MW Cornelia","year":"2021","unstructured":"Cornelia MW, J\u00f6rg JG (2021) The immunology of rheumatoid arthritis. Nat Immunol 22(1):10\u201318. https:\/\/doi.org\/10.1038\/s41590-020-00816-x","journal-title":"Nat Immunol"},{"key":"10958_CR5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3389\/fimmu.2019.01198","volume":"10","author":"B Wolf-Henning","year":"2019","unstructured":"Wolf-Henning B, Nicolo CB (2019) Autoreactive T-Lymphocytes in inflammatory skin diseases. Front Immunol 10:1198. https:\/\/doi.org\/10.3389\/fimmu.2019.01198","journal-title":"Front Immunol"},{"key":"10958_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22141","author":"AK Bergmann","year":"2014","unstructured":"Bergmann AK, Schneppenheim S, Seifert M, Betts MJ, Haake A, Lopez C, Penas EMM, Vater I, Jayne S et al (2014) Recurrent mutation of\u00a0JAK 3\u00a0in t-cell prolymphocytic leukemia. Genes Chromosomes Cancer. https:\/\/doi.org\/10.1002\/gcc.22141","journal-title":"Genes Chromosomes Cancer"},{"key":"10958_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo4363","author":"C Chen","year":"2022","unstructured":"Chen C, Yin Y, Shi G, Zhou Y, Shao S, Wei Y, Wu L, Zhang D, Sun L, Zhang T (2022) A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing \u03b3c cytokine\u2013related JAK-STAT signal. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abo4363","journal-title":"Sci Adv"},{"key":"10958_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1039\/9781847557964-00349","volume":"1","author":"Z Chao","year":"2002","unstructured":"Chao Z, Sung-Hou K (2002) The impact of protein kinase structures on drug discovery. Nat Rev 1:309\u2013350. https:\/\/doi.org\/10.1039\/9781847557964-00349","journal-title":"Nat Rev"},{"issue":"3","key":"10958_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1182\/blood-2005-02-0707","volume":"106","author":"TJ Boggon","year":"2005","unstructured":"Boggon TJ, Li Y, Manley PW, Eck MJ (2005) Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog. Blood 106(3):996\u20131002. https:\/\/doi.org\/10.1182\/blood-2005-02-0707","journal-title":"Blood"},{"key":"10958_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003551","author":"MHH Berg","year":"2022","unstructured":"Berg MHH, Rinc\u00f3n SVD, Miller WH (2022) Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-003551","journal-title":"J Immunother Cancer"},{"issue":"20","key":"10958_CR11","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1182\/blood-2014-04-566687","volume":"124","author":"S Degryse","year":"2014","unstructured":"Degryse S, Bock CED, Cox L, Demeyer S, Gielen O, Mentens N, Jacobs K, Geerdens E, Gianfelici V, Hulselmans G, Fiers M, Aerts S, Meijerink JP, Tousseyn T, Cools J (2014) JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model. Blood 124(20):3092\u20133100. https:\/\/doi.org\/10.1182\/blood-2014-04-566687","journal-title":"Blood"},{"key":"10958_CR12","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8982","author":"D Ciobanu","year":"2020","unstructured":"Ciobanu D, Poenariu I, Cr\u00eengu\u0219 LI, Vreju F, Turcu-Stiolica A, Tica A, Padureanu V, Dumitrascu R, Banicioiu-Covei S, Dinescu S, Boldeanu L, Silo\u0219i I, Ungureanu A, Boldeanu M, Osiac E, Barbulescu A (2020) JAK\/STAT pathway in pathology of rheumatoid arthritis. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2020.8982","journal-title":"Exp Ther Med"},{"key":"10958_CR13","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1084\/jem.183.6.2687","volume":"183","author":"F Candotti","year":"1996","unstructured":"Candotti F, Oakes SA, Johnston JA, Notarangelo LD, O\u2019Shea JJ, Blaese RM (1996) In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J Exp Med 183:2687\u20132692. https:\/\/doi.org\/10.1084\/jem.183.6.2687","journal-title":"J Exp Med"},{"issue":"5","key":"10958_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1759720X10378372","volume":"2","author":"S Srinivasan","year":"2010","unstructured":"Srinivasan S, Ernest HC (2010) The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2(5):247\u2013256. https:\/\/doi.org\/10.1177\/1759720X10378372","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10958_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ (2021) The immunology of rheumatoid arthritis. Nat Immunol 22:10\u201318. https:\/\/doi.org\/10.1038\/s41590-020-00816-x","journal-title":"Nat Immunol"},{"issue":"1","key":"10958_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1759720X12470753","volume":"5","author":"C Maurizio","year":"2013","unstructured":"Maurizio C (2013) The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential. Ther Adv Musculoskelet Dis 5(1):3\u201311. https:\/\/doi.org\/10.1177\/1759720X12470753","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"7","key":"10958_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/biom10071002","volume":"10","author":"A Jacopo","year":"2020","unstructured":"Jacopo A, Rossella T, Rossana R, Giulia F, Giorgia B, Lisa DC, Serena B, Francesco S (2020) JAK-inhibitors for the treatment of rheumatoid arthritis: a focus on the present and an outlook on the future. Biomolecules 10(7):1002. https:\/\/doi.org\/10.3390\/biom10071002","journal-title":"Biomolecules"},{"issue":"4","key":"10958_CR18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.coph.2012.06.008","volume":"12","author":"A Kontzias","year":"2012","unstructured":"Kontzias A, Kotlyar A, Laurence A, O\u2019Shea JJ (2012) Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease. Curr Opin Pharmacol 12(4):464\u2013470. https:\/\/doi.org\/10.1016\/j.coph.2012.06.008","journal-title":"Curr Opin Pharmacol"},{"key":"10958_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.628144","author":"S Biswa Mohan","year":"2021","unstructured":"Biswa Mohan S, Ravi Kumar BVV, Shruti J, Manoj Kumar M, Bimal KB, Preetismita B (2021) Drug repurposing strategy (DRS): emerging approach to identify potential therapeutics for treatment of novel coronavirus infection. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.628144","journal-title":"Front Mol Biosci"},{"key":"10958_CR20","volume-title":"Drug repurposing (DR): an emerging approach in drug discovery","author":"R Mithun","year":"2020","unstructured":"Mithun R, Shubham J, Khairnar AGJ (2020) Drug Repurposing\u2014hypothesis, molecular aspects and therapeutic applications. Drug repurposing (DR): an emerging approach in drug discovery. IntechOpen"},{"key":"10958_CR21","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.chembiol.2016.10.008","volume":"23","author":"M Forster","year":"2016","unstructured":"Forster M, Chaikuad A, Bauer SM, Holstein J, Robers MB, Corona CR, Gehringer M, Pfaffenrot E, Ghoreschi K, Knapp S, Laufer SA (2016) Selective JAK3 inhibitors with a covalent reversible binding mode targeting a new induced fit binding pocket. Cell Chem Biol 23:1335\u20131340. https:\/\/doi.org\/10.1016\/j.chembiol.2016.10.008","journal-title":"Cell Chem Biol"},{"key":"10958_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open babel: an open chemical toolbox. J Cheminf. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"J Cheminf"},{"issue":"6","key":"10958_CR23","doi-asserted-by":"publisher","first-page":"e0234215","DOI":"10.1371\/journal.pone.0234215","volume":"15","author":"RI Awwad","year":"2020","unstructured":"Awwad RI, Gamal MM (2020) Docking studies and molecular dynamics simulations of the binding characteristics ofwaldiomycin and its methyl ester analog to Staphylococcus aureushistidine kinase. PLoS ONE 15(6):e0234215. https:\/\/doi.org\/10.1371\/journal.pone.0234215","journal-title":"PLoS ONE"},{"issue":"8","key":"10958_CR24","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/molecules23081899","volume":"23","author":"P Tatu","year":"2018","unstructured":"Tatu P, Antti P (2018) Binding affinity via docking: fact and fiction. Molecules 23(8):1899. https:\/\/doi.org\/10.3390\/molecules23081899","journal-title":"Molecules"},{"issue":"26","key":"10958_CR25","doi-asserted-by":"publisher","first-page":"139022","DOI":"10.1016\/j.cplett.2021.139022","volume":"781","author":"K Koichi","year":"2021","unstructured":"Koichi K, Tomoki N, Eiji K, Akifumi O (2021) Molecular dynamics simulations for the protein\u2013ligand complex structures obtained by computational docking studies using implicit or explicit solvents. Chem Phy Lett 781(26):139022. https:\/\/doi.org\/10.1016\/j.cplett.2021.139022","journal-title":"Chem Phy Lett"},{"issue":"11","key":"10958_CR26","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.3390\/su12114789","volume":"12","author":"KM Reza","year":"2020","unstructured":"Reza KM, Mark G, Neda KM, Ferry J, Kerry B, Sharon B, Ahmad AK (2020) Cross-docking: a systematic literature review. Sustainability 12(11):4789. https:\/\/doi.org\/10.3390\/su12114789","journal-title":"Sustainability"},{"key":"10958_CR27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1103\/PhysRev.136.B864","volume":"136","author":"P Hohenberg","year":"1964","unstructured":"Hohenberg P, Kohn W (1964) In homogeneous electron gas. Phys Rev B 136:864\u2013871. https:\/\/doi.org\/10.1103\/PhysRev.136.B864","journal-title":"Phys Rev B"},{"key":"10958_CR28","unstructured":"Frisch, M.J., et al. (2009) Gaussian 09, Revision B. 01. Gaussian, Inc., Wallingford"},{"issue":"3","key":"10958_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0006-3495(03)74962-5","volume":"84","author":"S Wolfgang","year":"2003","unstructured":"Wolfgang S, J\u00fcrgen S, Peter K, Axel W (2003) MD simulation of protein-ligand interaction: formation and dissociation of an insulin-phenol complex. Biophys J 84(3):1493\u20131506. https:\/\/doi.org\/10.1016\/S0006-3495(03)74962-5","journal-title":"Biophys J"},{"key":"10958_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00355047","volume":"10","author":"DFM Van Aalten","year":"1996","unstructured":"Van Aalten DFM, Bywater R, Findlay JBC, Hendlich M, Hooft RWW, Vriend G (1996) PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J Computer-Aided Mol Des 10:255\u2013262","journal-title":"J Computer-Aided Mol Des"},{"issue":"3","key":"10958_CR31","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/prot.26267","volume":"90","author":"SK Nagarajan","year":"2022","unstructured":"Nagarajan SK, Sathya B, Panneer D, Honglae S, Thirumurthy M (2022) Structure and dynamics of the somatostatin receptor 3-ligand binding in the presence of lipids examined using computational structural biology methods. Proteins 90(3):704\u2013719. https:\/\/doi.org\/10.1002\/prot.26267","journal-title":"Proteins"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-10958-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-10958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T08:21:26Z","timestamp":1747297286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-10958-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10958"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-10958-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3791539\/v1","asserted-by":"object"}]},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"22 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}